Moving From Health Disparity to Health Equity: Addressing Social Determinants of Health to Improve CKD Outcomes
Socioeconomic status influences chronic kidney disease (CKD) risk. Socioeconomic disparities intertwine with racial, geographic and health care disparities. One result:…
By the Numbers: Optimize Sites for Your Nephrology-Related Trials With Frenova
See how Frenova’s impact on CKD and ESRD clinical trials compares to industry averages. The numbers don’t lie: our clinical…
Aim Higher: Advocate for Increased Funding and Research
Chronic kidney disease (CKD) is a common disease with a relatively high prevalence in the adult population. However, it receives…
How Do You Keep Your Trials Moving Forward When Patients Can’t Come to Your Office? FRENOVA KNOWS
Learn how Frenova is helping sites continue clinical research during the COVID-19 pandemic.
How Do You Keep Studies Progressing When The World Stands Still?
Learn what Frenova has been doing to keep studies on track during the COVID-19 pandemic.